Stuart Collinson - Profile and Investment Details

Investor Profile

Stuart Collinson is a Incubator based in San Diego, United States with a diverse investment portfolio that includes companies such as Altair Therapeutics, Nereus Pharmaceuticals, Morphotek, Concurrent Thinking, Soleno Therapeutics, Inc., NovaCardia, Predix Pharmaceuticals, AGY TherapeuticsAsteres, Conforma Therapeutics, ZoBio, SpotQA, Micromet, Vertex Pharmaceuticals, Baxter Healthcare, Ambit Biosciences, Sequel Pharmaceuticals, Hypnion, Imagine Pharmaceuticals, Gryphon Therapeutics, Acorda Therapeutics, Tioga Pharmaceuticals, Cabrellis Pharmaceuticals, Adiana, Affinium Pharmaceuticals, Dynavax Technologies, Proprius Pharmaceuticals, Sanarus Medical, TargeGen, Oxagen, Viracta Therapeutics, LigoCyte Pharmaceuticals, Syndax Pharmaceuticals, Kemia, . Over time, Stuart Collinson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Stuart Collinson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Engineering, Information Services, Information Technology (IT), Mobile, Software, Biotechnology, Clinical Trials, Research, Web Development, Medical, B2B, Therapeutics, Pharmaceuticals, Application Performance Management may find it worthwhile to explore potential connections with Stuart Collinson, as their portfolio suggests a familiarity and interest in this area.

Understanding Stuart Collinson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.